{"id":"aspirin-80","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Gastrointestinal bleeding"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"2-5","effect":"Nausea"},{"rate":"<1","effect":"Hemorrhagic stroke"},{"rate":"<1","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin acetylates serine residues on COX-1 and COX-2 enzymes, permanently blocking their catalytic activity. This prevents the synthesis of thromboxane A2 in platelets, which is essential for platelet activation and clot formation. At low doses (such as 80 mg), aspirin preferentially affects platelet function, making it effective for antiplatelet therapy without significantly inhibiting protective prostaglandins in the gastrointestinal tract.","oneSentence":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing the production of thromboxane A2 and other prostaglandins to decrease platelet aggregation and inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:18.650Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction prevention"},{"name":"Ischemic stroke prevention"},{"name":"Transient ischemic attack (TIA) prevention"},{"name":"Stable angina pectoris"}]},"trialDetails":[{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT07456085","phase":"PHASE3","title":"Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves","status":"ENROLLING_BY_INVITATION","sponsor":"Rawalpindi Institute of Cardiology","startDate":"2025-11-13","conditions":"Valvular Heart Disease Patients","enrollment":60},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT03934021","phase":"","title":"Gut Microbiota in Acute Stroke Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-07-01","conditions":"Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":120},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT03907046","phase":"PHASE3","title":"Anticoagulation in ICH Survivors for Stroke Prevention and Recovery","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-01-28","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation","enrollment":700},{"nctId":"NCT04184921","phase":"PHASE2","title":"Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients","status":"COMPLETED","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2019-01-01","conditions":"Lung Cancer Non-small Cell Stage IV","enrollment":216},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT05105919","phase":"EARLY_PHASE1","title":"Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2021-08-26","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT03121209","phase":"PHASE3","title":"Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Columbia University","startDate":"2018-01-18","conditions":"Internal Carotid Artery Stenosis, Cognitive Impairment","enrollment":385},{"nctId":"NCT03819101","phase":"PHASE3","title":"Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-06-06","conditions":"Prostate Cancer","enrollment":1210},{"nctId":"NCT06509893","phase":"PHASE4","title":"Ticagrelore Alone Post PCI","status":"RECRUITING","sponsor":"Shiraz University of Medical Sciences","startDate":"2024-08-01","conditions":"Coronary Artery Disease","enrollment":5400},{"nctId":"NCT06965244","phase":"PHASE3","title":"Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-01","conditions":"Cutaneous Lupus Erythematosus (CLE)","enrollment":122},{"nctId":"NCT06653348","phase":"PHASE2, PHASE3","title":"Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke","status":"RECRUITING","sponsor":"Mazandaran University of Medical Sciences","startDate":"2024-04-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":100},{"nctId":"NCT06280976","phase":"PHASE4","title":"Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2024-03-01","conditions":"Coronary Artery Disease, Atherosclerosis, Heart Attack","enrollment":""},{"nctId":"NCT03543683","phase":"PHASE2","title":"Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC","status":"COMPLETED","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2018-01-01","conditions":"Non-Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, EGFR T790M","enrollment":115},{"nctId":"NCT06425133","phase":"PHASE2","title":"Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2024-07-19","conditions":"Metastatic Colorectal Cancer","enrollment":174},{"nctId":"NCT04534218","phase":"PHASE2","title":"Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2020-10-16","conditions":"Colo-rectal Cancer, Metastatic Cancer","enrollment":49},{"nctId":"NCT05462613","phase":"PHASE2, PHASE3","title":"Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2023-05-09","conditions":"Metastatic Colorectal Cancer","enrollment":446},{"nctId":"NCT00251576","phase":"PHASE3","title":"Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1999-11-01","conditions":"Acute Coronary Syndrome","enrollment":4497},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04122170","phase":"PHASE2","title":"Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old","status":"COMPLETED","sponsor":"SFJ Pharmaceuticals, Inc.","startDate":"2019-09-24","conditions":"Healthy","enrollment":207},{"nctId":"NCT03464305","phase":"PHASE3","title":"ASPIRIN Trial Belgium","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2018-02-22","conditions":"Colon Cancer","enrollment":148},{"nctId":"NCT02301286","phase":"PHASE3","title":"A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leiden University","startDate":"2015-01","conditions":"Colon Cancer, Adjuvant Therapy","enrollment":770},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT02133521","phase":"PHASE2, PHASE3","title":"DLBS1033 for Acute Ischemic Stroke Patients","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-11-11","conditions":"Acute Ischemic Stroke, Partial Anterior Circulation Infarct, Lacunar Anterior Circulation Infarct","enrollment":80},{"nctId":"NCT01938248","phase":"PHASE4","title":"Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2015-05","conditions":"Atrial Fibrillation, Stroke","enrollment":4012},{"nctId":"NCT04273516","phase":"PHASE2, PHASE3","title":"Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2020-08-22","conditions":"Stroke, Prevention","enrollment":42},{"nctId":"NCT04738097","phase":"PHASE3","title":"Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2021-08-08","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":90},{"nctId":"NCT06018688","phase":"PHASE2","title":"Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.","status":"NOT_YET_RECRUITING","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2023-09-15","conditions":"Non Small Cell Lung Cancer, EGFR Gene Mutation","enrollment":44},{"nctId":"NCT02976701","phase":"PHASE2, PHASE3","title":"Effect of DLBS1033 After Primary PCI in Patients With STE-ACS","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2016-11","conditions":"ST Elevation Myocardial Infarction","enrollment":23},{"nctId":"NCT06019741","phase":"PHASE4","title":"Rivaroxaban Post Coronary Bypass Surgery","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2021-02-01","conditions":"Post Coronary Bypass Surgery Patients","enrollment":234},{"nctId":"NCT03703635","phase":"NA","title":"Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2018-10-17","conditions":"Intracranial Artery Stenosis","enrollment":512},{"nctId":"NCT05858918","phase":"NA","title":"Ticagrelor vs. Clopidogrel in Post PCI Patients","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2022-10-01","conditions":"Stable Chronic Angina","enrollment":476},{"nctId":"NCT05705089","phase":"PHASE3","title":"Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction","enrollment":50},{"nctId":"NCT05632445","phase":"PHASE4","title":"Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)","status":"COMPLETED","sponsor":"DR. XAVIER FREIXA","startDate":"2019-05-01","conditions":"Left Atrial Appendage Occlusion","enrollment":160},{"nctId":"NCT04132791","phase":"NA","title":"TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease","status":"TERMINATED","sponsor":"Leiden University Medical Center","startDate":"2019-10-07","conditions":"Cardiovascular Diseases","enrollment":328},{"nctId":"NCT03873649","phase":"","title":"Immune Response in Hypersensitivity Pneumonitis","status":"COMPLETED","sponsor":"Nabeel Hamzeh","startDate":"2018-11-29","conditions":"Hypersensitivity Pneumonitis","enrollment":21},{"nctId":"NCT05210725","phase":"PHASE4","title":"Trained Immunity by Dual-pathway Inhibition in Coronary Artery Disease","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-03-01","conditions":"Coronary Artery Disease","enrollment":20},{"nctId":"NCT04498273","phase":"PHASE3","title":"COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80","status":"TERMINATED","sponsor":"Frank C Sciurba","startDate":"2020-09-07","conditions":"COVID-19","enrollment":657},{"nctId":"NCT04038489","phase":"PHASE2","title":"COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2019-10-18","conditions":"Breast Cancer, Estrogen Receptor-positive Breast Cancer","enrollment":""},{"nctId":"NCT04695106","phase":"PHASE4","title":"Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2021-10-25","conditions":"Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome","enrollment":2230},{"nctId":"NCT04863053","phase":"","title":"Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2015-04-02","conditions":"Coronary Disease","enrollment":266},{"nctId":"NCT02565693","phase":"PHASE2","title":"Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2014-09","conditions":"Cerebral Hemorrhage, Atrial Fibrillation","enrollment":101},{"nctId":"NCT04792723","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet","status":"UNKNOWN","sponsor":"Vita Green Health Products Co. Ltd","startDate":"2021-03-05","conditions":"Cardiovascular Diseases","enrollment":24},{"nctId":"NCT04754789","phase":"PHASE3","title":"Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-02-20","conditions":"ST Elevation Myocardial Infarction","enrollment":160},{"nctId":"NCT00486512","phase":"PHASE3","title":"Chemoprevention of Colorectal Adenomas","status":"TERMINATED","sponsor":"Colotech A/S","startDate":"2007-06","conditions":"Adenomatous Polyps","enrollment":350},{"nctId":"NCT00535925","phase":"PHASE4","title":"Nephropathy In Type 2 Diabetes and Cardio-renal Events","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2005-10","conditions":"Diabetic Nephropathy","enrollment":850},{"nctId":"NCT03532698","phase":"","title":"Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)","status":"UNKNOWN","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2020-08-01","conditions":"Non-Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, EGFR T790M","enrollment":100},{"nctId":"NCT03867461","phase":"NA","title":"The Effects of MAP and EtCO2 on Venous Sinus Pressures","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-06-20","conditions":"Idiopathic Intracranial Hypertension","enrollment":8},{"nctId":"NCT02922673","phase":"NA","title":"The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2016-09","conditions":"Endotoxemia","enrollment":30},{"nctId":"NCT02646488","phase":"NA","title":"Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2015-08","conditions":"Cardiovascular Disease, High Blood Pressure","enrollment":276},{"nctId":"NCT00799045","phase":"PHASE4","title":"Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects","status":"COMPLETED","sponsor":"Laval University","startDate":"2008-10","conditions":"Migraine","enrollment":220},{"nctId":"NCT02295826","phase":"PHASE2","title":"Dabigatran Following Transient Ischemic Attack and Minor Stroke","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2015-01","conditions":"Transient Ischemic Attack, Minor Ischemic Stroke","enrollment":300},{"nctId":"NCT01352234","phase":"PHASE4","title":"Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2011-09","conditions":"Pre-Eclampsia, Fetal Growth Retardation, Premature Birth","enrollment":104},{"nctId":"NCT01355705","phase":"PHASE1, PHASE2","title":"Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Michaela Liedtke","startDate":"2011-08","conditions":"Multiple Myeloma","enrollment":14},{"nctId":"NCT03648970","phase":"PHASE2","title":"Indonesia Pravastatin to Prevent Preeclampsia Study","status":"UNKNOWN","sponsor":"Universitas Airlangga","startDate":"2018-03-01","conditions":"Pre-Eclampsia","enrollment":280},{"nctId":"NCT02145988","phase":"PHASE2, PHASE3","title":"DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2015-06-03","conditions":"Diabetes, Peripheral Arterial Disease","enrollment":11},{"nctId":"NCT02640794","phase":"PHASE4","title":"Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI","status":"COMPLETED","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2015-01","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":222},{"nctId":"NCT00496769","phase":"PHASE3","title":"A Phase III Study of Apixaban in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-08-31","conditions":"Atrial Fibrillation","enrollment":6421},{"nctId":"NCT00576693","phase":"PHASE3","title":"Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2008-10","conditions":"Ischemic Stroke","enrollment":451},{"nctId":"NCT02951234","phase":"NA","title":"A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-09","conditions":"Kawasaki Disease","enrollment":278},{"nctId":"NCT02707094","phase":"NA","title":"A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain","status":"COMPLETED","sponsor":"Brooke Army Medical Center","startDate":"2013-01","conditions":"Chronic Low Back Pain","enrollment":75},{"nctId":"NCT03263299","phase":"PHASE4","title":"Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2017-08","conditions":"Invitro Fertilization","enrollment":120},{"nctId":"NCT03195153","phase":"PHASE4","title":"Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2017-03-28","conditions":"Diabetes Mellitus Type 2 Platelets Reactivity Statin","enrollment":200},{"nctId":"NCT01559298","phase":"PHASE4","title":"Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial","status":"COMPLETED","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2012-03","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":178},{"nctId":"NCT02362984","phase":"PHASE3","title":"DLBS1033 for the Treatment of Acute Ischemic Stroke","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-10","conditions":"Acute Ischemic Stroke","enrollment":9},{"nctId":"NCT02146664","phase":"PHASE2, PHASE3","title":"DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization","status":"WITHDRAWN","sponsor":"Dexa Medica Group","startDate":"2015-11","conditions":"Acute Non-ST Elevation Myocardial Infarction","enrollment":""},{"nctId":"NCT02694848","phase":"PHASE4","title":"Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection","status":"UNKNOWN","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2016-02","conditions":"Angina","enrollment":120},{"nctId":"NCT01447498","phase":"NA","title":"Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2011-04","conditions":"Coronary Occlusion/Thrombosis, Peptic Ulcer Hemorrhage","enrollment":2024},{"nctId":"NCT02331511","phase":"NA","title":"Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2015-10","conditions":"Complication of Cardiac Defibrillator, Disorder of Cardiac Pacemaker System, Venous Occlusion","enrollment":100},{"nctId":"NCT00728286","phase":"","title":"Assessment of Thrombogenicity in Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2008-10","conditions":"Type 2 Diabetes Mellitus, Acute Coronary Syndrome","enrollment":90},{"nctId":"NCT01790997","phase":"PHASE3","title":"Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Dexa Medica Group","startDate":"2012-05","conditions":"Acute Ischemic Stroke","enrollment":126},{"nctId":"NCT00153062","phase":"PHASE4","title":"PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-08","conditions":"Stroke","enrollment":20332},{"nctId":"NCT01456247","phase":"PHASE3","title":"Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-03","conditions":"Gastric Ulcers, Duodenal Ulcers","enrollment":439},{"nctId":"NCT01900639","phase":"PHASE4","title":"Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2013-07","conditions":"Aspirin, Circadian Rhythm, Platelet Activation","enrollment":14},{"nctId":"NCT01303445","phase":"PHASE1","title":"Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2011-03","conditions":"Healthy","enrollment":60},{"nctId":"NCT01506505","phase":"NA","title":"The Evening Versus Morning Polypill Utilization Study","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2012-07","conditions":"Cardiovascular Disease, Cerebrovascular Disease, Peripheral Arterial Disease","enrollment":78},{"nctId":"NCT01101503","phase":"PHASE2","title":"The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes","status":"UNKNOWN","sponsor":"Xiang Guang-da","startDate":"2010-04","conditions":"Endothelial Dysfunction","enrollment":1000},{"nctId":"NCT00061373","phase":"PHASE2","title":"Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2003-05","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT01438580","phase":"PHASE4","title":"The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation","status":"COMPLETED","sponsor":"Nanjing Medical University","startDate":"2010-01","conditions":"Atrial Fibrillation","enrollment":260},{"nctId":"NCT01448031","phase":"PHASE1","title":"A Healthy Female and Male Volunteers Aspirin Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-11","conditions":"Healthy","enrollment":54},{"nctId":"NCT00815126","phase":"NA","title":"Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2008-11","conditions":"Aspirin Hypersensitivity, NSAIDs Hypersensitivity","enrollment":34},{"nctId":"NCT00930839","phase":"","title":"Role of Prostaglandins on Niacin-Induced Flushing","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2009-03","conditions":"Flushing","enrollment":30},{"nctId":"NCT00966485","phase":"NA","title":"Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2006-10","conditions":"Coronary Stenting","enrollment":106}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"MOVEMENT DISORDER"},{"count":1,"reaction":"ACTIVITIES OF DAILY LIVING IMPAIRED"},{"count":1,"reaction":"BENIGN BREAST NEOPLASM"},{"count":1,"reaction":"BLOOD GLUCOSE DECREASED"},{"count":1,"reaction":"BLOOD PRESSURE DECREASED"},{"count":1,"reaction":"BLOOD PRESSURE SYSTOLIC INCREASED"},{"count":1,"reaction":"CHAPPED LIPS"},{"count":1,"reaction":"CYANOSIS"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"ERYTHEMA"}],"_approvalHistory":[],"publicationCount":151,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Aspirin 80","genericName":"Aspirin 80","companyName":"Shiraz University of Medical Sciences","companyId":"shiraz-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing the production of thromboxane A2 and other prostaglandins to decrease platelet aggregation and inflammation. Used for Acute myocardial infarction prevention, Ischemic stroke prevention, Transient ischemic attack (TIA) prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}